Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
Go back to Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting| (NASDAQ: TRVI) | Delayed: 12.61 -0.33 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.94 | 52 Week High | $ | |||
| Open | $12.74 | 52 Week Low | $ | |||
| Day High | $12.74 | P/E | N/A | |||
| Day Low | $12.39 | EPS | $ | |||
| Volume | 1,377,028 | |||||



